Amgen, Inc. (AMGN)
367.29
+0.71
(+0.19%)
USD |
NASDAQ |
Feb 12, 10:05
Amgen Shareholders Equity (Quarterly) : 8.658B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 22.62B |
| Johnson & Johnson | -- |
| Eli Lilly & Co. | -- |
| Merck & Co., Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.59B |
| Total Liabilities (Quarterly) | 81.93B |
| Debt to Equity Ratio | 6.307 |
| Current Ratio | 1.14 |
| Net Debt Paydown Yield | 0.66% |